Lastly, FOXO1 is seen to have potential involvement in diseases like esophageal adenocarcinomas [71], type 2 diabetes mellitus, Parkinson's disease [72], metabolic syndrome [73], cardiovascular diseases, aging, and stem-cell activity [74]. This evidence concerns the gene FOXO1 and Parkinson disease.